The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Surgical Treatment of Adenocarcinoma of the Rectum
Open accessAbstract
OBJECTIVE: The authors' aim was to determine survival and recurrence rates in patients undergoing resection of rectal cancer achieved by abdominoperineal resection (APR), coloanal anastomosis (CAA), and anterior resection (AR) without adjuvant therapy. SUMMARY BACKGROUND DATA: The surgery of rectal cancer is controversial; so, too, is its adjuvant management. Questions such as preoperative versus postoperative radiation versus no radiation are key. An approach in which the entire mesorectum is excised has been proposed as yielding low recurrence rates. METHODS: Of 1423 patients with resected rectal cancers, 491 patients were excluded, leaving 932 with a primary adenocarcinoma of the rectum treated at Mayo. Eighty-six percent were resected for cure. Surgery plus adjuvant treatment was performed in 418, surgery alone in 514. These 514 patients are the subject of this review. Among the 514 patients who underwent surgery alone, APR was performed in 169, CAA in 19, AR in 272, and other procedures in 54. Eighty-seven percent of patients were operated on with curative intent. The mean follow-up was 5.6 years; follow-up was complete in 92%. APR and CAA were performed excising the envelope of rectal mesentery posteriorly and the supporting tissues laterally from the sacral promontory to the pelvic floor. AR was performed using an appropriately wide rectal mesentery resection technique if the tumor was high; if the tumor was in the middle or low rectum, all mesentery was resected. The mean distal margin achieved by AR was 3 +/- 2 cm. RESULTS: Mortality was 2% (12 of 514). Anastomotic leaks after AR occurred in 5% (16 of 291) and overall transient urinary retention in 15%. Eleven percent of patients had a wound infection (abdominal and perineal wound, 30-day, purulence, or cellulitis). The local recurrence and 5-year disease-free survival rates were 7% and 78%, respectively, after AR; 6% and 83%, respectively, after CAA; and 4% and 80%, respectively, after APR. Patients with stage III disease, had a 60% disease-free survival rate. CONCLUSIONS: Complete resection of the envelope of supporting tissues about the rectum during APR, CAA, and AR when tumors were low in the rectum is associated with low mortality, low morbidity, low local recurrence, and good 5-year survival rates. Appropriate "tumor-specific" mesorectal excision during AR when the tumor is high in the rectum is likewise consistent with a low rate of local recurrence and good long-term survival. However, the overall failure rate of 40% in stage III disease (which is independent of surgical technique) means that surgical approaches alone are not sufficient to achieve better long-term survival rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER
Heald, R. J., & Ryall, R. D. H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91510-2 · Cited by 2,710
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Mesorectal excision for rectal cancer
MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90207-w · Cited by 1,781
Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
(1995) · PubMed · Cited by 759
Scott, N., Jackson, P., Al-Jaberi, T., Dixon, M. F., Quirke, P., & Finan, P. J. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800820808 · Cited by 335
Holm, T., Johansson, H., Cedermark, B., Ekelund, G., & Rutqvist, L.-E. (1997) · British Journal of Surgery · doi:10.1002/bjs.1800840520 · Cited by 248
Analysis of local recurrence rates after surgery alone for rectal cancer
McCall, J. L., Cox, M. R., & Wattchow, D. A. (1995) · International Journal of Colorectal Disease · doi:10.1007/bf00298532 · Cited by 246
Tveit, K. M., Guldvog, I., Hagen, S., Trondsen, E., Harbitz, T., Nygaard, K., Nilsen, J. B., Wist, E., & On behalf of the Norwegian adjuvant Rectal Cancer Project Group (1997) · British Journal of Surgery · doi:10.1002/bjs.1800840827 · Cited by 229
Cited by
Guidelines 2000 for Colon and Rectal Cancer Surgery
Nelson, H., Petrelli, N., Carlin, A., Couture, J., Fleshman, J., Guillem, J., Miedema, B., Ota, D., & Sargent, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.583 · Cited by 1,283
Al-Sukhni, E., Milot, L., Fruitman, M., Beyene, J., Victor, J. C., Schmocker, S., Brown, G., McLeod, R., & Kennedy, E. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2210-5 · Cited by 576
Law, W. L., & Chu, K. W. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133185.23514.32 · Cited by 475
Fujita, S., Mizusawa, J., Kanemitsu, Y., Ito, M., Kinugasa, Y., Komori, K., Ohue, M., Ota, M., Akazai, Y., Shiozawa, M., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002212 · Cited by 439
Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer
Sugihara, K., Kobayashi, H., Kato, T., Mori, T., Mochizuki, H., Kameoka, S., Shirouzu, K., & Muto, T. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0714-z · Cited by 427
Metadata
- Authors
- Zaheer, S., Pemberton, J. H., Farouk, R., Dozois, R. R., Wolff, B. G., & Ilstrup, D.
- Venue
- Annals of Surgery
- Published
- 1998-06
- Volume
- 227
- Issue
- 6
- Pages
- 800-811
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2033547644
- Cited by
- 312
- References
- 13
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surgical Treatment of Adenocarcinoma of the Rectum. https://app.cochat.ai/papers/10.1097/00000658-199806000-00003
- The paper
- Zaheer, S., Pemberton, J. H., Farouk, R., Dozois, R. R., Wolff, B. G., & Ilstrup, D. (1998). Surgical Treatment of Adenocarcinoma of the Rectum. Annals of Surgery. https://doi.org/10.1097/00000658-199806000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.